The use of antiendotoxin peptides in obstructive jaundice endotoxemia
European Journal of Gastroenterology & Hepatology, 02/22/2012Jones C et al.
This study demonstrates that novel antiendotoxin peptides may attenuate the hepatic inflammatory response in portal endotoxemia. In obstructive jaundice, preoperative peptide administration may reduce endotoxin–related postoperative complications.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.